Skip to main navigation Skip to search Skip to main content

How European Research Projects Can Support Vaccination Strategies: The Case of the ORCHESTRA Project for SARS-CoV-2

  • Anna Maria Azzini
  • , Lorenzo Maria Canziani
  • , Ruth Joanna Davis
  • , Massimo Mirandola
  • , Michael Hoelscher
  • , Laurence Meyer
  • , Cédric Laouénan
  • , Maddalena Giannella
  • , Jesús Rodríguez-Baño
  • , Paolo Boffetta
  • , Dana Mates
  • , Surbhi Malhotra-Kumar
  • , Gabriella Scipione
  • , Caroline Stellmach
  • , Eugenia Rinaldi
  • , Jan Hasenauer
  • , Evelina Tacconelli
  • University of Verona
  • Ludwig Maximilian University of Munich
  • German Center for Infection Research (DZIF), Partner Site Munich
  • Université Paris-Saclay
  • Université Paris Cité
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • University of Bologna
  • Hospital Universitario Virgen Macarena
  • Instituto de Salud Carlos III
  • National Institute of Public Health
  • University of Antwerp
  • Cineca Consortium of Universities
  • Charité-Universitätsmedizin Berlin
  • University of Bonn
  • Helmholtz Zentrum München - German Research Center for Environmental Health

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

ORCHESTRA (“Connecting European Cohorts to Increase Common and Effective Response To SARS-CoV-2 Pandemic”) is an EU-funded project which aims to help rapidly advance the knowledge related to the prevention of the SARS-CoV-2 infection and the management of COVID-19 and its long-term sequelae. Here, we describe the early results of this project, focusing on the strengths of multiple, international, historical and prospective cohort studies and highlighting those results which are of potential relevance for vaccination strategies, such as the necessity of a vaccine booster dose after a primary vaccination course in hematologic cancer patients and in solid organ transplant recipients to elicit a higher antibody titer, and the protective effect of vaccination on severe COVID-19 clinical manifestation and on the emergence of post-COVID-19 conditions. Valuable data regarding epidemiological variations, risk factors of SARS-CoV-2 infection and its sequelae, and vaccination efficacy in different subpopulations can support further defining public health vaccination policies.

Original languageEnglish
Article number1361
JournalVaccines
Volume11
Issue number8
DOIs
StatePublished - Aug 2023

Keywords

  • COVID-19
  • cohort study
  • data harmonization
  • fragile population
  • healthcare workers
  • public health
  • vaccination

Fingerprint

Dive into the research topics of 'How European Research Projects Can Support Vaccination Strategies: The Case of the ORCHESTRA Project for SARS-CoV-2'. Together they form a unique fingerprint.

Cite this